ストックスクリーナーアプリを入手
37.92
3.85%
-1.52
アフターアワーズ：
37.29
-0.63
-1.66%
前日終値:
$39.44
開ける：
$39.2
24時間の取引高:
620.55K
Relative Volume:
0.90
時価総額：
$1.40B
収益：
$154.15M
当期純損益:
$-33.58M
株価収益率:
-39.50
EPS:
-0.96
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
-6.53%
1か月 パフォーマンス:
-11.58%
6か月 パフォーマンス:
+62.40%
1年 パフォーマンス:
-30.83%
1日の値動き範囲:
$37.92
$40.50
1週間の範囲:
$36.83
$41.08
52週間の値動き範囲:
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
HROW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
37.92 | 1.46B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
143.26 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.88 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.20 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.63 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 開始されました | BTIG Research | Buy |
| 2025-06-10 | 開始されました | William Blair | Outperform |
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other (HROW) - Seeking Alpha
What does recent volatility data suggest for Harrow Inc.Price Action & Real-Time Volume Trigger Notifications - newser.com
How hedge fund analytics apply to Harrow Inc. stock2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
Harrow, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
On the Move: Oct. 14, 2025 - Nashville Post
Harrow, Inc. (NASDAQ:HROW) On The Verge Of Breaking Even - 富途牛牛
Will Harrow Inc. stock pay special dividendsOil Prices & Community Supported Trade Ideas - newser.com
What insider trading reveals about Harrow Inc. stockTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Harrow, Inc. Hits Day Low of $41.03 Amid Price Pressure - Markets Mojo
Advocate Group LLC Buys New Stake in Harrow, Inc. $HROW - MarketBeat
Harrow Health Announces New Leadership at ImprimisRx - MSN
Harrow (HROW): Assessing Valuation as Investor Day Highlights Growth Outlook and Expanding Ophthalmology Portfolio - simplywall.st
Is it too late to sell Harrow Inc.Earnings Growth Report & Real-Time Chart Breakout Alerts - newser.com
What data driven models say about Harrow Inc.’s futurePortfolio Risk Report & Weekly High Conviction Trade Ideas - newser.com
What institutional flow reveals about Harrow Inc.Dollar Strength & Entry and Exit Point Strategies - newser.com
Using data tools to time your Harrow Inc. exitJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Harrow (NASDAQ:HROW) - MarketBeat
Harrow, Inc. (HROW): A Bull Case Theory - Insider Monkey
Will Harrow's (HROW) Affordability Push and New Leadership Shift its Long-Term Growth Trajectory? - simplywall.st
Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage? - Yahoo Finance
Harrow, Inc. (HROW) Stock Analysis: Exploring The 61.71% Upside Potential - DirectorsTalk Interviews
ImprimisRx Announces Leadership Changes - GlobeNewswire
Is Harrow Inc. stock dividend yield sustainableWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
Harrow names Frank Mullery as CEO of ImprimisRx subsidiary - Investing.com
Harrow Health (HROW) Appoints New Leadership at ImprimisRx - GuruFocus
Harrow names Frank Mullery as CEO of ImprimisRx subsidiary By Investing.com - Investing.com Canada
ImprimisRx announces leadership changes - MarketScreener
Leadership Appointments at ImprimisRx: Frank Mullery Named CEO and Bridseida Cruz as Head of Quality - Quiver Quantitative
Frank Mullery named CEO; Bridseida Cruz named Head of Quality at ImprimisRx, Harrow subsidiary - Stock Titan
Intraday pattern recognizer results for Harrow Inc.Bull Run & Technical Pattern Recognition Alerts - newser.com
How to escape a deep drawdown in Harrow Inc.July 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Assessing Harrow’s Value After a 22.8% Surge and Recent Earnings Release - simplywall.st
How to track smart money flows in Harrow Inc.Market Volume Report & Smart Money Movement Alerts - newser.com
Harrow (NASDAQ:HROW) Trading Down 4.9%Should You Sell? - MarketBeat
A Fresh Look at Harrow (HROW) Valuation Following Recent Share Price Momentum - simplywall.st
Harrow, Inc. (NASDAQ:HROW) Looks Just Right With A 27% Price Jump - simplywall.st
Research Analysts Issue Forecasts for Harrow Q3 Earnings - MarketBeat
How to use Fibonacci retracement on Harrow Inc.2025 Top Gainers & High Yield Stock Recommendations - newser.com
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
Harrow Inc (HROW) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
0.05%
5.75%
大文字化:
|
ボリューム (24 時間):